Profilo
Olaf Elixmann has held positions as a member of the supervisory board at B.Braun Avitum AG and B.
Braun SE.
Currently, he holds the position of member of the supervisory board at both companies.
Posizioni attive di Olaf Elixmann
| Società | Posizione | Inizio |
|---|---|---|
B.Braun Avitum AG
 B.Braun Avitum AG Medical SpecialtiesHealth Technology B.Braun Avitum AG engages in the development, production, and distribution of medical and pharmaceutical products used in dialysis, plasmapheresis, and other blood treatments. It also operates dialysis stations, and provides medical and consulting services. The company was founded on October 5, 2000 and is headquartered in Melsungen, Germany. | Director/Board Member | - |
B. Braun SE
 B. Braun SE Pharmaceuticals: MajorHealth Technology Part of B. Braun Holding GmbH & Co. KG, B. Braun SE is a global healthcare company based in Melsungen, Germany. The German company offers a wide range of medical equipment and healthcare solutions, including efficient and life-saving extracorporeal blood treatments such as hemodialysis, acute dialysis, and apheresis. B. Braun has more than 360 dialysis and care centers worldwide, providing the best possible care for patients with chronic diseases. The private company was founded in 2018, and Anna Maria Braun has been the CEO of the company since 2019. | Director/Board Member | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 2 |
|---|---|
B. Braun SE
B. Braun SE Pharmaceuticals: MajorHealth Technology Part of B. Braun Holding GmbH & Co. KG, B. Braun SE is a global healthcare company based in Melsungen, Germany. The German company offers a wide range of medical equipment and healthcare solutions, including efficient and life-saving extracorporeal blood treatments such as hemodialysis, acute dialysis, and apheresis. B. Braun has more than 360 dialysis and care centers worldwide, providing the best possible care for patients with chronic diseases. The private company was founded in 2018, and Anna Maria Braun has been the CEO of the company since 2019. | Health Technology |
B.Braun Avitum AG
B.Braun Avitum AG Medical SpecialtiesHealth Technology B.Braun Avitum AG engages in the development, production, and distribution of medical and pharmaceutical products used in dialysis, plasmapheresis, and other blood treatments. It also operates dialysis stations, and provides medical and consulting services. The company was founded on October 5, 2000 and is headquartered in Melsungen, Germany. | Health Technology |
- Borsa valori
- Insiders
- Olaf Elixmann
